In the latest trading sessions, PGEN stock forecast signals have shifted to neutral-positive with Bollinger Bands tightening. Such compression often precedes strong price moves in the biotech sector. We can see that insiders own shares in Precigen, Inc.. It has a market capitalization of just US$455m, and insiders have US$43m worth of shares, in their own names. This shows at least some alignment. You can click here to see if those insiders have been buying or selling. Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor. Statistical regression models for PGEN stock forecast suggest a 60% probability of prices moving above $2.00 in the next 90 days if biotech sentiment remains stable.